Angioedema Latest Advances

Expanding the Diagnostic Lens: Mast Cell Activation Syndromes and the Hidden Spectrum of Angioedema Associated Mortality in COVID-19.

Journal: Academic forensic pathology

Published: January 19, 2026

Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity Study.

Journal: medRxiv : the preprint server for health sciences

Published: January 16, 2026

Monogenic and SLE-like disorders in the pediatric population: insights from a Northern Israel cohort.

Journal: Lupus

Published: January 14, 2026

Donidalorsen (Dawnzera) for prevention of hereditary angioedema attacks.

Journal: The Medical letter on drugs and therapeutics

Published: January 08, 2026

Garadacimab-gxii-A Novel Prophylactic Treatment for Hereditary Angioedema: A Drug Review.

Journal: The Annals of pharmacotherapy

Published: January 07, 2026

Abstracts of the 14th C1-inhibitor Deficiency and Angioedema Workshop.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: January 04, 2026

Correction to "Pharmacological Suppression of the Kallikrein Kinin System with KVD900: An Orally Available Plasma Kallikrein Inhibitor for the On-demand Treatment of Hereditary Angioedema".

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: December 29, 2025

Intestinal Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Diagnosis of Exclusion.

Journal: Cureus

Published: December 19, 2025

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 18, 2025

Seropositive Myasthenia Gravis Triggered by Lyme Disease: A Case Study of Molecular Mimicry.

Journal: Cureus

Published: December 15, 2025

Scombroid and Anaphylaxis: Different Diseases Despite Featural Similarities.

Journal: Cureus

Published: December 04, 2025

Long-term Prophylaxis With Lanadelumab in Patients With Angioedema Due to C1 Inhibitor Deficiency: A Real-life Study in Spain.

Journal: Journal of investigational allergology & clinical immunology

Published: December 03, 2025